1. Poly-sgRNA/siRNA ribonucleoprotein nanoparticles for targeted gene disruption.
- Author
-
Ha JS, Lee JS, Jeong J, Kim H, Byun J, Kim SA, Lee HJ, Chung HS, Lee JB, and Ahn DR
- Subjects
- Animals, Cell Survival drug effects, Drug Carriers, Gene Targeting, HeLa Cells, Humans, Male, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Particle Size, RNA, Small Interfering administration & dosage, Ribonuclease III chemistry, Ribonucleoproteins toxicity, CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, Endonucleases chemistry, Nanoparticles chemistry, RNA, Guide, CRISPR-Cas Systems chemistry, RNA, Small Interfering chemistry, Ribonucleoproteins chemistry
- Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein-9 nuclease (Cas9) can be used for the specific disruption of a target gene to permanently suppress the expression of the protein encoded by the target gene. Efficient delivery of the system to an intracellular target site should be achieved to utilize the tremendous potential of the genome-editing tool in biomedical applications such as the knock-out of disease-related genes and the correction of defect genes. Here, we devise polymeric CRISPR/Cas9 system based on poly-ribonucleoprotein (RNP) nanoparticles consisting of polymeric sgRNA, siRNA, and Cas9 endonuclease in order to improve the delivery efficiency. When delivered by cationic lipids, the RNP nanoparticles built with chimeric poly-sgRNA/siRNA sequences generate multiple sgRNA-Cas9 RNP complexes upon the Dicer-mediated digestion of the siRNA parts, leading to more efficient disruption of the target gene in cells and animal models, compared with the monomeric sgRNA-Cas9 RNP complex., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF